14th Jul 2020 12:10
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 13 JULY 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,414,594 | 1.10% | 446,322 | 0.35% | ||
(2) | Derivatives (other than options): | ||||
383,000 | 0.30% | 383,659 | 0.30% | ||
(3) | Options and agreements to | ||||
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
(4) | TOTAL: | ||||
1,797,594 | 1.40% | 829,981 | 0.64% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 204.5800 USD |
Purchase | 5 | 201.7500 USD |
Purchase | 15 | 201.4783 USD |
Purchase | 20 | 201.4475 USD |
Purchase | 37 | 202.8100 USD |
Purchase | 70 | 202.4542 USD |
Purchase | 100 | 202.7500 USD |
Purchase | 134 | 203.8100 USD |
Purchase | 320 | 203.0913 USD |
Purchase | 347 | 202.1280 USD |
Purchase | 410 | 202.3743 USD |
Purchase | 500 | 203.0620 USD |
Purchase | 760 | 203.0946 USD |
Purchase | 770 | 203.4660 USD |
Purchase | 853 | 202.6985 USD |
Purchase | 962 | 202.3535 USD |
Purchase | 1,200 | 203.7808 USD |
Purchase | 1,200 | 203.7809 USD |
Purchase | 2,003 | 203.0606 USD |
Purchase | 2,592 | 201.4700 USD |
Purchase | 3,413 | 203.1758 USD |
Purchase | 4,558 | 203.2099 USD |
Purchase | 5,010 | 202.9384 USD |
Purchase | 10,868 | 202.6088 USD |
Sale | 1 | 201.4600 USD |
Sale | 7 | 202.5900 USD |
Sale | 19 | 201.5505 USD |
Sale | 22 | 204.0200 USD |
Sale | 100 | 203.3100 USD |
Sale | 100 | 203.9000 USD |
Sale | 100 | 203.7550 USD |
Sale | 100 | 203.5600 USD |
Sale | 100 | 203.5550 USD |
Sale | 100 | 202.7300 USD |
Sale | 112 | 203.7200 USD |
Sale | 160 | 203.9025 USD |
Sale | 181 | 201.6031 USD |
Sale | 300 | 203.7950 USD |
Sale | 384 | 203.6671 USD |
Sale | 578 | 203.7874 USD |
Sale | 642 | 203.3397 USD |
Sale | 642 | 203.1645 USD |
Sale | 749 | 201.9632 USD |
Sale | 1,200 | 203.7808 USD |
Sale | 2,095 | 201.4700 USD |
Sale | 2,771 | 203.1379 USD |
Sale | 5,494 | 202.1979 USD |
Sale | 6,904 | 203.0036 USD |
Sale | 12,515 | 203.0623 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
unit | |||
SWAP | Long | 1 | 160,088,020.0000 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure | 14 JULY 2020 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200714005564/en/
Copyright Business Wire 2020
Related Shares:
Barclays